Foley球囊联合缩宫素用于Bishop评分≤3的引产:二次分析
该研究为随机多中心试验的二次分析,纳入151例Bishop评分≤3的孕妇,比较宫内Foley球囊联合缩宫素与单用Foley球囊引产。联合组引产至分娩时间更短(21.3 vs 27小时,P=.005),24小时内分娩率更高(74% vs 46%,P=.001),需额外促宫颈成熟剂更少(4% vs 15%,P=.04),但缩宫素输注时间更长(19.1 vs 12.4小时,P<.001)。两组剖宫产、产后出血、绒毛膜羊膜炎及新生儿ICU入住率无差异。
要点
- Bishop评分≤3者,Foley球囊联合缩宫素可缩短引产至分娩时间。
- 联合组24小时内分娩率更高(74% vs 46%),需额外促宫颈成熟剂更少。
- 联合组缩宫素输注时间更长,但母婴不良结局无差异。
核心结论
- Bishop评分≤3的孕妇,Foley球囊联合缩宫素较单用Foley球囊显著缩短引产至分娩时间,尤其在经产妇中。
研究设计与样本
- 随机多中心试验的二次分析,纳入151例Bishop评分≤3、孕≥24周单活胎引产孕妇,联合组77例,单用组74例。
主要发现
- 联合组引产至分娩时间短于单用组(21.3 vs 27小时,P=.005),调整BMI、产次及初始Bishop评分后仍显著(21.5 vs 26.7小时,P=.007)。
- 联合组24小时内分娩率更高(74% vs 46%,P=.001),需额外促宫颈成熟剂更少(4% vs 15%,P=.04)。
- 单用组缩宫素输注时间更短(12.4 vs 19.1小时,P<.001)。
- 两组≤12小时分娩率、剖宫产率、产后出血、绒毛膜羊膜炎及新生儿ICU入住率无差异。
关键数值与推荐
- Bishop评分≤3者,联合组引产至分娩时间21.3小时,单用组27小时(P=.005)。
- 联合组24小时内分娩率74%,单用组46%(P=.001)。
- 联合组需额外促宫颈成熟剂4%,单用组15%(P=.04)。
- 联合组缩宫素输注时间19.1小时,单用组12.4小时(P<.001)。
临床怎么用
- 对Bishop评分≤3的引产孕妇,可考虑Foley球囊联合缩宫素以缩短分娩时间,尤其经产妇。
- 需注意联合方案缩宫素输注时间更长,应加强监测。
局限性
- 为二次分析,样本量有限(151例),结论需进一步验证。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The combination method for cervical ripening with a Foley catheter and concurrent oxytocin administration has been shown to reduce the total time from induction to delivery when compared with a Foley catheter only in patients with an unfavorable cervix (Bishop score of <6). It is unclear if this is still effective for patients with a less favorable cervix as indicated by a Bishop score of ≤3. OBJECTIVE: This study aimed to determine if inducing labor with a Foley catheter and concurrent oxytocin administration reduced the total time from induction to delivery in subjects with a Bishop score of ≤3 compared with those who only received a Foley catheter without oxytocin for cervical ripening. STUDY DESIGN: This was a secondary analysis of a randomized, multicenter trial of patients with a live singleton pregnancy at ≥24 weeks' gestation undergoing labor induction with a Foley catheter and a Bishop score of <6. This analysis included patients with a Bishop score of ≤3. Exclusions included >1 cesarean delivery, unexplained bleeding, nonreassuring fetal tracing, major fetal anomalies, or other contraindications for vaginal delivery. The subjects were randomized to receive an intracervical Foley catheter only or with concurrent oxytocin infusion. The primary outcome for this analysis was the time from induction to delivery. Secondary outcomes included delivery at ≤12 hours, time to delivery ≤24 hours, cesarean delivery, total time of oxytocin infusion, need for additional ripening agents, postpartum hemorrhage, chorioamnionitis, and neonatal intensive care unit admission. RESULTS: A total of 322 patients were enrolled in the primary trial; 151 subjects had an initial Bishop score of ≤3 and were included in the secondary analysis (n=77 for Foley catheter with oxytocin and n=74 for the Foley catheter only). The demographics were similar in both groups. Those with a Bishop score of ≤3 who received a Foley catheter with concurrent oxytocin administration had a shorter time from induction to delivery than those patients who received a Foley catheter only for cervical ripening (21.3 vs 27 hours; P=.005). The group with a Foley catheter and oxytocin administered concurrently also had a shorter time from induction to delivery after adjusting for body mass index, parity status, and first Bishop score (21.5 vs 26.7 hours; P=.007). They also were more likely to deliver within 24 hours (74% vs 46%; P=.001) and not to require additional ripening agents (4% vs 15%; P=.04). Patients with the Foley catheter only method were more likely to receive additional ripening agents, but had fewer hours of oxytocin infusion (19.1 vs 12.4 hours; P<.001). There was no difference in the rate of delivery at ≤12 hours, cesarean delivery, postpartum hemorrhage, chorioamnionitis, and neonatal intensive care unit admission. CONCLUSION: Concurrent Foley catheter and oxytocin infusion significantly reduced the time from induction to delivery in patients with a Bishop score of ≤3 when compared with a Foley catheter only, particularly in multiparous patients.
引用
- Gagnon J, Corlin T, Berghella V, et al. Intracervical Foley catheter with and without oxytocin for labor induction with Bishop score ≤3: a secondary analysis. Am J Obstet Gynecol MFM. 2021. PMID: 33757937. doi:10.1016/j.ajogmf.2021.100350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。